Precautionary recall of Ergometrine Injections (CLDA (17)A/01)
Recall of Ergometrine Injections by hameln pharmaceuticals limited because the contents of some ampoules may not comply with the required specification.
Medicine recalls page 21
Medicine recalls, drug alerts and medical device warnings from the MHRA. 609 listed.
Alka-Seltzer Original & Alka-Seltzer XS – recall of some batches due to an issue with the blister foil
(Bayer plc) Remaining stock of affected batches should be quarantined for uplift by Bayer - class 3 action within 5 days (EL (17)A/03)
Class 4 Caution in Use : Mirena 20 micrograms / 24 hours intrauterine delivery system
Bayer plc has informed us that they have received two complaints globally concerning Mirena inserters with an insertion tube which is mounted inversely to the handle
Class 4 Caution in Use: Arava 10mg film-coated tablets (Leflunomide)
Sanofi has informed us that there is an error in the Braille on some batches of Arava 10mg film-coated tablets (EL (17)A/01)
Class 4 Caution in Use: Amoxicillin Sugar Free Suspension 250mg/5ml & Amoxicillin Sugar Free Suspension 125mg/5ml
Medreich has provided handling instructions following several complaints that the child-resistant caps are difficult to open (EL(16)A/17)
Evacal D3 1500mg/400iu Chewable Tablets – metal contamination in a very small number of tablets
(Teva UK Limited) Precautionary batch recall of Evacal D3 1500mg/400iu Chewable Tablets after metal contamination was identified in a very small number of tablets
Hydrocortisone 100mg/1ml Solution for Injection – solution in some ampoules has a yellowish appearance
(Amdipharm UK Limited) Remaining stock of this batch should be quarantined and returned to the original supplier for credit - class 3 action within 5 days (EL (16)A/15)
Managing diabetes: patients should not change their insulin delivery device without checking with their healthcare specialist
If patients are contacted directly by a manufacturer or other organisation to try using a different insulin therapy system they should first discuss this with their diabetes specialist to avoid risk of hyperglycaemia, hypoglycaemia…
Nacrez 75 microgram Film-coated Tablets (Desogestrel) PL 00289/1706
Action Within 48 Hours. Wholesaler and Pharmacy Level Recall. Teva UK Limited is recalling batches due to out of specification results for impurities obtained during routine stability testing.
Adalat LA 60mg Tablets incorrectly packaged in 30mg carton (CLDA (16)A/08)
Quadrant Pharmaceuticals Limited (repackaged by Pharmagen Limited) are asking pharmacists to check stocks of Adalat LA 30mg as there is a possibility that some packs of Parallel Imported LA 60mg may have been incorrectly…
Chlorhexidine Gluconate 2%w/v impregnated pad – precautionary recall (CLDA (16)A/07)
Sage Products Cooperatief UA: Precautionary recall of five batches due to low risk of microbiological contamination
Class 4 Caution in Use: EcoLab Klerpack BD Syringe Multi-Pack
Ecolab are recalling batches of Klerpack BD Syringe Multi-Pack as the sterile packaging may contain small holes in the film of the pouch. (EL (16)A/13)
GlucaGen HypoKit 1mg (glucagon) PL 04668/0027 (GlucaGen 1mg) PL 04668/0028 (Solvent for GlucaGen 1mg)
Action within 48 hours: Novo Nordisk Ltd. is recalling seven batches of GlucaGen HypoKit due to a small number of needles being detached from the syringe.
Accu-Chek® Insight Insulin pump system: risk of over- or under-infusion of insulin
Manufactured by Roche Diabetes Care - inadequately detailed handling instructions of the 'Key Lock' function of the pump may lead to unintentional operation, which could result in rapid and severe deterioration of health e.g.…
Class 4 Caution in Use: Actilyse 20mg and 50mg powder and solvent for solution for injection and infusion (alteplase)
Reports that rubber stopper may be pushed into vial during reconstitution, rendering the vial unusable. (EL (16)A/11)
Helixate NexGen – (CLDA (16)A/06)
CSL Behring is recalling the listed batches due to reduced potency of the active ingredient.
Kogenate Bayer Powder and Solvent for Solution for Injection – (CLDA (16)A/05)
Bayer is recalling the listed batches due to reduced potency of the active ingredient
Furosemide-Claris 20mg/2ml Injection – AUST R 148003, intended for the Australian market (CLDA (16)A/04)
Claris Lifesciences UK Ltd are asking pharmacists and wholesalers to check packs of Furosemide-Claris 20mg/2ml Injection (Marketing Authorisation number AUST R 148003) as they have been inadvertently distributed in the UK and are intended…
Respontin Nebules 250micrograms/1ml & Respontin Nebules 500micrograms/2ml (Ipratropium Bromide)
Action within 48 hours: Glaxo Wellcome UK Ltd is recalling 4 batches of Respontin Nebules due to out of specification results for impurities obtained during routine stability testing (EL (16)A/10)
Pemetrexed 25mg/ml Concentrate for solution for Infusion – particulates in small number of vials
Caduceus Pharma Ltd., Pemetrexed 25mg/ml Concentrate for solution for Infusion: caution in use after particulates identified in a small number of vials (EL (16)A/09)
Medikinet XL 20mg modified-release capsules (methylphenidate hydrochloride)
Action within 48 hours: B&S Healthcare are recalling two batches of parallel imported Medikinet XL 20mg modified-release capsules that have been incorrectly repackaged in 30mg cartons. (EL (16)A/08)
Ikervis 1 mg/ml eye drops, emulsion (ciclosporin) – micro particles of active ingredient
(Santen UK Ltd) Two batches of Ikervis 1 mg/ml eye drops, emulsion (30 single dose containers) (ciclosporin), are being recalled because micro particles of the active ingredient were found in stability test samples (EL(16)A/07)
Epistatus 10mg in 1ml Oromucosal Solution – fault with neck adaptor
(Special Products Ltd) A batch of Epistatus 10mg in 1ml Oromucosal Solution is being recalled due to the wrong size of neck adaptor in some bottles (EL (16)A/06)
Paclitaxel 6mg/ml concentrate for solution for infusion; 100mg in 16.7ml – exterior of vials potentially contaminated with Methotrexate
(Hospira UK Limited) Paclitaxel 6mg/ml concentrate for solution for infusion; 100mg in 16.7ml - risk of the exterior of vials contaminated with Methotrexate (EL (16)A/05)